Insider · CIK 0001697422
Christopher R. Fenimore
Files at REGN (REGENERON PHARMACEUTICALS, INC.). First filing -, latest -.
Christopher R. Fenimore files SEC Form 4 as CFO at REGN (REGENERON PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher R. Fenimore has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Common Stock | +3,027 | $0.00 | $0 | 19,292 | Dec 9, 2025 |
| Dec 8, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -992 | $712.94 | $707k | 18,300 | Dec 9, 2025 |
| Dec 5, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +14,924 | $0.00 | $0 | 14,924 | Dec 9, 2025 |
| Dec 16, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -491 | $730.81 | $359k | 16,265 | Dec 18, 2024 |
| Dec 6, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Common Stock | +2,591 | $0.00 | $0 | 17,896 | Dec 10, 2024 |
| Dec 9, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -1,140 | $787.00 | $897k | 16,756 | Dec 10, 2024 |
| Dec 6, 2024 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +9,979 | $0.00 | $0 | 9,979 | Dec 10, 2024 |
Questions about Christopher R. Fenimore
Answered from the filings on this page, as of the latest one.
Is Christopher R. Fenimore buying or selling?
Christopher R. Fenimore has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher R. Fenimore's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher R. Fenimore has 0.
Where does Christopher R. Fenimore file Form 4?
Christopher R. Fenimore has filed Form 4 at REGN (REGENERON PHARMACEUTICALS, INC.) as EVP Finance CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.